Initial conditions | Fraction of simulation runs with identical starting conditions that ended in the immune hyper-response due to the agent types given. | |||||
---|---|---|---|---|---|---|
(Conditions in Figure 2) | T1 | T2 | B1 | B2 | CTL | Number of runs |
10 DCs | 0.07 | 0.93 | 0.07 | 0.29 | 0 | 14 |
20 DCs | 0 | 0.89 | 0.22 | 0.22 | 0 | 9 |
30 DCs | 0.38 | 0.75 | 0.25 | 0.25 | 0 | 8 |
40 DCs | 0.57 | 0.57 | 0.43 | 0.29 | 0 | 7 |
50 DCs | 0 | 1.0 | 0 | 0 | 0 | 1 |
60 DCs | 0.93 | 0.29 | 0.93 | 0 | 0 | 14 |
70 DCs | 0.89 | 0.26 | 0.89 | 0.05 | 0 | 19 |
80 DCs | 1.0 | 0.25 | 1.0 | 0 | 0 | 4 |
90 DCs | 1.0 | 0.12 | 0.75 | 0.12 | 0 | 8 |
100 DCs | 1.0 | 0.18 | 1.0 | 0.09 | 0 | 11 |
No DC apoptosis | ||||||
50 DCs | 0.86 | 0.09 | 0.32 | 0.03 | 0.11 | 66 |
Exclusion of CTLs from the simulated immune response | ||||||
20 DCs | 0.17 | 0.83 | 0.25 | 0 | 0 | 12 |
50 DCs | 0.83 | 0.33 | 0.83 | 0 | 0 | 6 |
80 DCs | 0.86 | 0.57 | 0.86 | 0.14 | 0 | 7 |
Exclusion of NKs from the simulated immune response | ||||||
20 DCs | 0.09 | 0.91 | 0.09 | 0.36 | 0 | 22 |
50 DCs | 0.50 | 0.67 | 0.46 | 0.29 | 0.04 | 24 |
80 DCs | 0.79 | 0.38 | 0.69 | 0.14 | 0 | 29 |
Exclusion of MΦs from the simulated immune response | ||||||
20 DCs | 0.10 | 0.84 | 0.10 | 0.16 | 0 | 19 |
50 DCs | 0.64 | 0.45 | 0.64 | 0.09 | 0 | 11 |
80 DCs | 1.0 | 0 | 1.0 | 0 | 0 | 1 |
More DCs recruited at immune activation | ||||||
20 DCs | 0.50 | 0.22 | 0.28 | 0 | 0.02 | 40 |
50 DCs | 0.68 | 0.25 | 0.54 | 0.04 | 0.11 | 28 |
80 DCs | 0.87 | 0.17 | 0.74 | 0.09 | 0.13 | 23 |
Increased CTL proliferation at activation | ||||||
20 DCs | 0.10 | 0.30 | 0.10 | 0 | 0.70 | 10 |
50 DCs | 0.26 | 0.17 | 0.35 | 0 | 0.87 | 23 |
80 DCs | 0.50 | 0 | 0.50 | 0 | 1.0 | 4 |